The Global Initiative For Chronic Obstructive Lung Disease : A Case Study

| 1. corticosteroid 2. bronchodilator 3. ACE inhibitor4. cholesterol 5. benzodiazepine 6. potassium sparing diuretic

This is a case study on a 76 year old man.Mr Alan Chari(pseudonym used to protect the identity of a patient),was admitted over night in my department.He is a divorcee who stays with son.He is a retired teacher and his son is permanently employed by a local company as an electrician.He is independent with activities of daily livings but is occasionally limited by his ill health.He used to be a heavy smoker .After realising the burden COPD has on general New Zealand population ,affecting about15% of the adult population over the age of 45 years according to asthmanz( 2010) ,l took this case study to gain in-depth understanding.

1345). Higher levels of albuterol may be detected, when comparing blood work in individuals who have had large doses of albuterol using an HFA inhaler compared to in individual who had received large doses using a CFC inhaler (Hendeles, Colice, & Meyer, 2007, p. 1346). Also, some HFA inhalers can be made without the use of other substances (Hendeles, Colice, & Meyer, 2007, p. 1347).  For example, Ventolin HFA is made with just albuterol sulfate and HFA (Hendeles, Colice, & Meyer, 2007, p. 1347).  The lack of ingredients allows for better tolerability by patients (Hendeles, Colice, & Meyer, 2007, p. 1347). Also, excess doses in the devices have more consistent drug doses in HFA inhalers than the CFC inhalers (Hendeles, Colice, & Meyer, 2007, p.

When an asthmatic takes an inhaler “Albuterol sulfate”, the medication works by reducing the inflammation in the airway paths “bronchi and bronchioles” of the lungs, allowing the patient to breath without constriction or symptoms of asthma.

D.Z.is a 65-year-old man admitted to medical ward with an exacerbation of chronic obstructive pulmonary disease (COPD; emphysema). Past medical history (PMH) indicates hypertension (HTN), well managed with enalapril (Vasotec) past six years, diagnosis (Dx) of pneumonia yearly for the past three years. D.Z. appears cachectic with difficulty breathing at rest. Patient reports productive cough with thick yellow-green sputum. He seems anxious and irritable during subjective data collection. He states, he has been a 2-pack-a-day smoker for 38 years. He complains of (c/o) insomnia and

R.W. appears with progressive difficulty getting his breath while doing simple tasks, and also having difficulty doing any manual work, complains of a cough, fatigue, and weight loss, and has been treated for three respiratory infections a year for the past 3 years. On physical examination, CNP notice clubbing of his fingers, use accessory muscles for respiration, wheezing in the lungs, and hyperresonance on percussion of the lungs, and also pulmonary function studies show an FEV1 of 58%. These all symptoms and history represented here most strongly indicate the probability of chronic obstructive pulmonary disease (COPD). COPD is a respiratory disease categorized by chronic airway inflammation, a decrease in lung function over time, and gradual damage in quality of life (Booker, 2014).

Acute severe asthma previously called status asthmaticus is a life threatening medical condition characterized by bouts of repeated and worsening cough, wheezing, chest recession and inability to speak or drink that may result in acute respiratory failure and even death.1 These patients are also at risk for developing serious complications like aspiration pneumonia, pneumo-mediastinum, pneumothorax and hypoxic brain injury etc. 1Inhaled high dose short acting β2 agonists like salbutamol along with systemic steroids and supplemental oxygen are considered as first line treatment in all patients who

Patients had to measure their IC by using an incentive spirometer to measure static lung values. They performed this test for 20 minutes after inhaling 400 mg of salbutamol via a nebulizer. The patients were asked to use the FVC spirometer and told to take a deep breath and then to let the breath out passively. They were then asked to do the same maneuver 2 more times, but the closeness made the study choose the first attempt.

Albuterol; is a bronchodilator which means it will open and relax the breathing passages in your lungs. This will treat your wheezing, when you have shortness of breath, and a cough. Side effects that may occur are a shaking, nervous feeling, nausea and dizziness.

Mr. Joseph is a 56-year-old has 30 smoking pack years. He was diagnosed 10 years ago with asthma/chronic bronchitis, arthritis of the knees, and congestive heart failure (CHF). Mr. Joseph weighs 350 pounds with a height of 6 feet, making his body mass index (BMI) of 47.5, much more than the recommended 25, and in fact his BMI places him in the morbid obesity classification. He takes medicines for his pulmonary conditions, along with a diuretic.

During the second week of my clinical rotation, I had the privilege of being with the respiratory department, as a result of that my research of the Continuity of Care topic will be based on the topic of COPD (Chronic Obstructive Pulmonary Disease). COPD patients are usually readmitted due to acute exacerbations also known as (AECOPD). (Laverty et al., 2015). In this paper, we explore the COPD discharge care bundles which have been developed by different authors. The care bundle consists of a short list of certain evidence-based practices to be utilized or implemented before discharge for all patients who have been admitted with COPD, based on reviewing national guidelines, evidenced based practices, expert opinion, other relevant literature, peer-reviewed journals and patient consultation. (Hopkinson et al., 2012).

All over the world, chronic obstructive pulmonary disease (COPD) is a very significant and prevalent cause of morbidity and mortality, and it is increasing with time (Hurd, 2000; Pauwels, 2000; Petty, 2000). Due to the factor of COPD being an underdiagnosed and undertreated disease, the epidemiology (Pauwels, Rabe, 2004) is about 60 to 85 % with mild or moderate COPD remaining undiagnosed (Miravitlles et al., 2009; Hvidsten et al., 2010).

Elliot will be educated on the new medications. He will learn that Atrovent is a long-acting puffer versus Ventolin is a short-acting puffer. He will be advised to take Atrovent as directed and make sure he is compliant on taking it daily in order to assist in controlling his symptoms in the long run. He would be informed that Atrovent will not help with shortness of breath on exertion. Therefore, if he feels like he needs quick relief of his symptoms, he needs to use the Ventolin puffer as a rescue puffer for shortness of breath.

“Teaching patients about promoting, maintaining, and restoring their health is a required nursing skill that most often results in a positive outcome, enhancing the patient 's quality of life” (Lewis et al., 2014, p.52). The intent of this analysis is to educate patients with chronic obstructive pulmonary disease on means that can enhance their quality of life and avert the progression of their disease. More specifically, it will focus on the aspect of teaching Mrs. N, a patient, how to effectively handle certain symptoms experienced with techniques like pursed-lip breathing and also, to upsurge the client’s awareness on preventative measures to abate the possibility of acute exacerbations. Mrs. N is a 100-years-old woman of Canadian and Arabic background. In mid-September, she was rushed to the hospital after experiencing worsening dyspnea and a fever. The doctors deduced a diagnosis of pneumonia and therefore, she was transferred to the medical unit at the Lakeshore hospital in order to be treated with intravenous antibiotics. Mrs. N has a past medical history of chronic obstructive pulmonary disease, hypertension, anemia, deep vein thrombosis and mixed dementia. Mrs. N is a retired widow with two daughters, who come and visit her on a daily basis at the hospital and encourage her to mobilize and eat because she has an extremely poor appetite on most days. She’s well cared for by a team of care workers in the nursing home where she lives and her daughters and

Some of the laboratory testing used to identify COPD are arterial blood gas and increased hematocrit levels. Arterial blood gas testing will reveals hypoxemia and hypercarbia due to the retention